只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-14 2026-07-16 | PTCT PTC THERAPEUTICS, INC. | Gravier Pierre Officer · CHIEF FINANCIAL OFFICER | 卖出（S） | 3,494 | US$80.35 | US$280,742.90 | 83,986 | SEC |
| 2026-07-09 2026-07-13 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 2,464 | US$90.25 | US$222,376.00 | 60,299 | SEC |
| 2026-07-09 2026-07-13 | PTCT PTC THERAPEUTICS, INC. | Smith Mary L. Director | 卖出（S） | 10,000 | US$90.00 | US$900,000.00 | 21,813 | SEC |
| 2026-07-09 2026-07-13 | PTCT PTC THERAPEUTICS, INC. | Smith Mary L. Director | 卖出（S） | 5,834 | US$90.00 | US$525,060.00 | 21,813 | SEC |
| 2026-07-07 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 11,369 | US$89.03 | US$101.22万 | 69,587 | SEC |
| 2026-07-07 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 9,288 | US$89.44 | US$830,718.72 | 60,299 | SEC |
| 2026-07-07 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 3,956 | US$87.17 | US$344,844.52 | 80,956 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 426 | US$85.28 | US$36,329.28 | 60,684 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 385 | US$86.34 | US$33,240.90 | 60,299 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 8,786 | US$85.35 | US$749,885.10 | 70,389 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 10,090 | US$86.32 | US$870,968.80 | 60,299 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 2,474 | US$87.03 | US$215,312.22 | 60,299 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 313 | US$83.10 | US$26,010.30 | 107,225 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 833 | US$84.41 | US$70,313.53 | 106,392 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 519 | US$85.84 | US$44,550.96 | 105,873 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 601 | US$86.38 | US$51,914.38 | 105,272 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 387 | US$83.10 | US$32,159.70 | 107,698 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 1,036 | US$84.41 | US$87,448.76 | 106,662 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 645 | US$85.84 | US$55,366.80 | 106,017 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 745 | US$86.38 | US$64,353.10 | 105,272 | SEC |
| 2026-06-26 2026-06-30 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 412 | US$85.23 | US$35,114.76 | 60,137 | SEC |
| 2026-06-26 2026-06-30 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 7,718 | US$85.26 | US$658,036.68 | 60,137 | SEC |
| 2026-06-25 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 419 | US$86.39 | US$36,197.41 | 60,137 | SEC |
| 2026-06-25 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 8,522 | US$85.26 | US$726,585.72 | 71,474 | SEC |
| 2026-06-25 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 11,337 | US$86.51 | US$980,763.87 | 60,137 | SEC |
| 2026-06-25 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 100 | US$87.00 | US$8,700.00 | 60,137 | SEC |
| 2026-06-25 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 582 | US$85.24 | US$49,609.68 | 60,556 | SEC |
| 2026-06-24 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 401 | US$85.01 | US$34,089.01 | 60,137 | SEC |
| 2026-06-24 2026-06-26 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 4,922 | US$85.03 | US$418,517.66 | 60,137 | SEC |
| 2026-06-22 2026-06-24 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 11,619 | US$81.21 | US$943,578.99 | 60,137 | SEC |
| 2026-06-22 2026-06-24 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 12,130 | US$80.61 | US$977,799.30 | 71,756 | SEC |
| 2026-06-17 2026-06-22 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 1,850 | US$79.24 | US$146,594.00 | 105,272 | SEC |
| 2026-06-17 2026-06-22 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 1,703 | US$78.50 | US$133,685.50 | 105,581 | SEC |
| 2026-06-17 2026-06-22 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 309 | US$79.25 | US$24,488.25 | 105,272 | SEC |
| 2026-06-17 2026-06-22 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 6,600 | US$78.50 | US$518,100.00 | 107,122 | SEC |
| 2026-06-17 2026-06-22 | PTCT PTC THERAPEUTICS, INC. | Utter Christine Marie Officer · SVP, CHIEF ACCOUNTING OFFICER | 卖出（S） | 19,686 | US$75.56 | US$148.75万 | 70,199 | SEC |
| 2026-06-10 2026-06-12 | PTCT PTC THERAPEUTICS, INC. | Pauwels Eric Officer · CHIEF BUSINESS OFFICER | 卖出（S） | 3,711 | US$75.00 | US$278,325.00 | 73,411 | SEC |
| 2026-06-10 2026-06-12 | PTCT PTC THERAPEUTICS, INC. | Pauwels Eric Officer · CHIEF BUSINESS OFFICER | 卖出（S） | 17,566 | US$75.00 | US$131.75万 | 73,411 | SEC |
| 2026-05-15 2026-05-19 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 456 | US$72.67 | US$33,137.52 | 105,212 | SEC |
| 2026-05-15 2026-05-19 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 2,356 | US$72.08 | US$169,820.48 | 105,668 | SEC |
| 2026-05-14 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | Klein Matthew B. Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 7,221 | US$73.08 | US$527,710.68 | 398,670 | SEC |
| 2026-05-14 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | Klein Matthew B. Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 679 | US$73.06 | US$49,607.74 | 405,891 | SEC |
| 2026-05-14 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | Klein Matthew B. Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 2,100 | US$73.08 | US$153,468.00 | 396,570 | SEC |
| 2026-05-14 2026-05-15 | PTCT PTC THERAPEUTICS, INC. | Klein Matthew B. Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 2,572 | US$72.46 | US$186,367.12 | 393,998 | SEC |
| 2026-05-08 2026-05-12 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 840 | US$78.23 | US$65,713.20 | 107,112 | SEC |
| 2026-05-08 2026-05-12 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 1,900 | US$79.31 | US$150,689.00 | 105,212 | SEC |
| 2026-05-08 2026-05-12 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 200 | US$78.00 | US$15,600.00 | 105,812 | SEC |
| 2026-05-08 2026-05-12 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 600 | US$79.28 | US$47,568.00 | 105,212 | SEC |
| 2026-04-21 2026-04-23 | PTCT PTC THERAPEUTICS, INC. | Klein Matthew B. Director,Officer · CHIEF EXECUTIVE OFFICER | 卖出（S） | 2,850 | US$70.91 | US$202,093.50 | 394,070 | SEC |
| 2026-04-06 2026-04-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 822 | US$68.91 | US$56,644.02 | 106,655 | SEC |
| 2026-04-06 2026-04-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 1,443 | US$69.75 | US$100,649.25 | 105,212 | SEC |
| 2026-04-02 2026-04-06 | PTCT PTC THERAPEUTICS, INC. | Golden Lee Scott Officer · EVP & CHIEF MEDICAL OFFICER | 卖出（S） | 829 | US$67.99 | US$56,363.71 | 79,115 | SEC |
| 2026-04-01 2026-04-03 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 39,393 | US$68.89 | US$271.38万 | 72,747 | SEC |
| 2026-04-01 2026-04-03 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 80 | US$70.30 | US$5,624.00 | 60,137 | SEC |
| 2026-04-01 2026-04-03 | PTCT PTC THERAPEUTICS, INC. | Almstead Neil Gregory Officer · CHIEF TECHNICAL OPS OFFICER | 卖出（S） | 12,530 | US$69.50 | US$870,835.00 | 60,217 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PTCT | 1,168,781.8001 | 13,704.0147 | 2,108,571.2042 | 55.43% | B, Q, N |